BRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial AdenocarcinomaEstrogen Receptor NegativeHER2/Neu NegativeHigh Grade Ovarian Serous AdenocarcinomaProgesterone Receptor NegativeRecurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7Stage IV Uterine Corpus Cancer AJCC v7Triple-Negative Breast Carcinoma
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2-Negative Breast CarcinomaHormone Receptor-Positive Breast Carcinoma
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chem…
Birmingham, United StatesEst. completion May 31, 2032
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell CarcinomaCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell CarcinomaStage IB2 Cervical Cancer AJCC v6 and v7Stage II Cervical Cancer AJCC v7Stage II Vaginal Cancer AJCC v6 and v7Stage IIA Cervical Cancer AJCC v7Stage IIB Cervical Cancer AJCC v6 and v7Stage III Vaginal Cancer AJCC v6 and v7Stage IIIB Cervical Cancer AJCC v6 and v7Stage IV Vaginal Cancer AJCC v6 and v7Stage IVA Cervical Cancer AJCC v6 and v7Stage IVA Vaginal Cancer AJCC v6 and v7Unresectable Vaginal CarcinomaVaginal AdenocarcinomaVaginal Adenosquamous CarcinomaVaginal CarcinomaVaginal Squamous Cell Carcinoma, Not Otherwise Specified
This randomized phase III trial studies radiation therapy and cisplatin with triapine to see how well they work compared…
Birmingham, United StatesEst. completion Jan 26, 2023